The Role of the Innate Immune System in Oncolytic Virotherapy.

The Role of the Innate Immune System in Oncolytic Virotherapy.
复制标题

DOI:
10.1155/2017/6587258
复制
发表时间:
2017
影响因子:
--
通讯作者:
Tian JP
Tian JP
中科院分区:
工程技术4区
文献类型:
--
作者:
Phan TA;Tian JP

文献摘要

参考文献

被引文献

相似文献

免疫反应的复杂性是当前病毒疗法的主要挑战。这项研究将先天免疫反应纳入我们的病毒治疗基本模型中,并研究先天免疫如何影响病毒治疗的结果。病毒治疗动态很大程度上取决于病毒爆发大小、相对先天免疫杀伤率和相对先天免疫衰减率。当病毒爆发量不太大时,先天免疫可能会以创造更多平衡的方式使病毒疗法复杂化,而当病毒爆发量很大时,动力学与没有先天免疫的系统相似。
The complexity of the immune responses is a major challenge in current virotherapy. This study incorporates the innate immune response into our basic model for virotherapy and investigates how the innate immunity affects the outcome of virotherapy. The viral therapeutic dynamics is largely determined by the viral burst size, relative innate immune killing rate, and relative innate immunity decay rate. The innate immunity may complicate virotherapy in the way of creating more equilibria when the viral burst size is not too big, while the dynamics is similar to the system without innate immunity when the viral burst size is big.
DOI: 10.3934/mbe.2011.8.841
发表时间: 2011-07-01
影响因子: 2.6
作者:
Tian, Jianjun Paul
通讯作者: Tian, Jianjun Paul
裂解周期:溶瘤病毒疗法的决定性过程
DOI: 10.1016/j.apm.2012.12.004
发表时间: 2013-04-15
影响因子: 5
作者:
Wang, Yujie;Tian, Jianjun Paul;Wei, Junjie
通讯作者: Wei, Junjie
DOI: 10.1158/2326-6066.cir-14-0015
发表时间: 2014-04
影响因子: 10.1
作者:
Chiocca EA;Rabkin SD
通讯作者: Rabkin SD
DOI: 10.1006/bulm.2001.0245
发表时间: 2001-07-01
影响因子: 3.5
作者:
Wu, JT;Byrne, HM;Wein, LM
通讯作者: Wein, LM
DOI: 10.1186/1745-6150-1-6
发表时间: 2006-02-17
期刊: Biology direct
影响因子: 5.5
作者:
Novozhilov AS;Berezovskaya FS;Koonin EV;Karev GP
通讯作者: Karev GP